LRP8 and neuroblastoma: Our data demonstrate that targeting SELENOP uptake via LRP8 is a valuable strategy to efficiently disrupt GPX4 maintenance and trigger ferroptosis in cultured MYCN‐amplified neuroblastoma cells.